How much funding has Insulet raised?

Insulet has raised $103.0M in total funding, most recently a Series E round.

Who are Insulet's investors?

Insulet's investors include Prism Venture Partners, Kodiak Venture Partners, OrbiMed, Alta Partners, Pequot Capital Management.

Where is Insulet headquartered?

Insulet is headquartered in Acton, Massachusetts, United States.

What industry is Insulet in?

Insulet operates in Healthcare, medtech.

How many employees does Insulet have?

Insulet has 1001-5000 employees.

Insulet

IPO

Born of empathy, driven by ingenuity, proven by science

Public · Acton, United States · Founded 2000 · $103.0M raised

Healthcare

medtech

Headquarters: Acton, Massachusetts
Employees: 1001–5000
Founded: 2000
Business Model: B2B2C
Website: insulet.com

Total Funding: $103.0M
Last Round: $50.0M Series EFeb 2006
Rounds: 5
Type: Public

About

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company headquartered in Acton, Massachusetts, dedicated to transforming the lives of people with diabetes and other conditions through its Omnipod product platform. Founded in 2000, Insulet pioneered the tubeless, waterproof Omnipod insulin pump system, which eliminates the need for multiple daily injections and the tubing associated with traditional pumps. The Omnipod 5 is the first tubeless automated insulin delivery system. Insulet's products are accessible in 25 countries across North America, Europe, the Middle East, and Asia Pacific.

Summary

Insulet is a Healthcare company based in Acton, United States, founded in 2000. It has raised $103.0M in total across 5 rounds, most recently a $50.0M Series E round in Feb 2006. Investors include Prism Venture Partners, Kodiak Venture Partners and OrbiMed.